WebbFör 1 dag sedan · Reviewers at the FDA were leaning toward rejecting Sarepta Therapeutics Inc's closely watched gene therapy for Duchenne muscular dystrophy. A top official had to intervene earlier this year, Stat News reported citing three people with direct knowledge of the agency deliberations. Inside the FDA office that oversees gene … WebbSarepta is engineering solutions for rare diseases with science that is on the forefront of precision genetic medicine. Our platforms include: gene therapy, RNA technologies, and …
Sarepta Therapeutics Announces Positive Functional Results from …
WebbFör 1 dag sedan · Several Food and Drug Administration staffers were leaning heavily toward rejecting a highly watched gene therapy from Sarepta Therapeutics (), according … Webb28 nov. 2024 · CAMBRIDGE, Mass., Nov. 28, 2024 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare … gonzaga games this season
SRPT: Sarepta Therapeutics Inc - Stock Price, Quote and News
WebbFör 1 dag sedan · Altamira Therapeutics CYTO-17%. ViewRay VRAY -18% dips after prelim Q1 revenue miss, outlook cut; explores options. Sarepta Therapeutics SRPT -12% hints at early FDA opposition to gene therapy. BigBear.ai Holdings BBAI -11% on offering of 113.25M shares by holders. Innovative Eyewear L LUCY-11%. Kalera Public Limited … Webbför 7 timmar sedan · SAN DIEGO, April 14, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces its ongoing investigation into potential violations of U.S. federal securities laws by Sarepta Therapeutics ... Webb13 apr. 2024 · Sarepta Therapeutics (NASDAQ: SRPT) stock is taking a beating on Thursday following reports that the Food and Drug Administration (FDA) was … health fitness corporation salaries